The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

Brain Research

Volumn 892, Issue 1, 2001, Pages 63-69

  Gao, Xuemei ^a   Dluzen, Dean E ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Corpus Striatum; Dopamine; Estrogen; Gender differences; Parkinson's disease

Indexed keywords

DOPAMINE; ESTROGEN; METHAMPHETAMINE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GONADECTOMY; HORMONAL THERAPY; MALE; MOUSE; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DRUG IMPLANTS; FEMALE; MALE; METHAMPHETAMINE; MICE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; ORCHIECTOMY; OVARIECTOMY; POTASSIUM; SUBSTANTIA NIGRA; TESTOSTERONE;

EID: 0035895834     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03221-2     Document Type: Article

References (44)

1. Stereotyped behavior elicited by amphetamine in the rat: Influences of the testes
2. Time-dependent changes in brain biogenic amine dynamics following castration in male rats
3. Temporal effects of castration on emotionality and shock-induced aggression in adult male rats
4. Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats
5. Psychoendocrine investigations in schizophrenia: Relationship between pituitary-gonadal function and behavior
6. Influence of sex, age and strain of MPTP-induced neurotoxicity
7. The influence of estrogen on monoamine oxidase activity
8. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
9. Long-term effect of MPTP in the mouse brain in relation to aging: Neurochemical and immunocytochemical analysis
10. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
11. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice
12. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine
13. Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system
14. Estrogen as a modulator of striatal dopaminergic neurotoxicity
15. The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat
16. Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system
17. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: Implications for Parkinson's Disease
18. Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release
19. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice
20. Effects of orchidectomy on nigrostriatal dopaminergic function: Behavioral and physiological evidence
21. In vitro progesterone modulates amphetamine-stimulated dopamine release from the corpus striatum of castrated male rats treated with estrogen
22. Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats
23. Effects of amfonelic acid, α-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
24. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system
25. Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice
26. Estradiol and dehydroepiandrosterone but not dihydrotestosterone protect against MPTP-induced dopamine depletion in mice
27. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treatment than young adults
28. Community networks for response to abuse outbreaks of methamphetamine and its analogs
29. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources
30. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicity
31. Neuropathological changes in the caudate nucleus elicited by MPTP and their prevention by monoamine oxidase inhibition
32. Characterization of the striatal dopamine receptor supersensitivity produced by estrogen-treatment of male rats
33. Estrogen-treatment increases the density of D1 dopamine receptors in the rat striatum
34. Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor
35. Effects of estrogen-treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice
36. Differential effects of estrogen and androgen on locomotor activity induced in castrated male rats by amphetamine, a novel environment, or apomorphine
37. The impact of gender and estrogen on striatal dopaminergic neurotoxicity
38. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats
39. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice
40. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity
41. Oestradiol-17 beta increases the firing rate of antidromically identified neurones of the rat neostriatum
42. Sexual differences in sensitivity to methamphetamine toxicity
43. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice
44. Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity